Schistosomiasis and soil-transmitted helminthiases: progress report, 2025
Weekly epidemiological record
Overview
Considerable progress has been made in reducing the burden of schistosomiasis and STH. The estimated STH burden measured in disability-adjusted life years (DALYs) had decreased from 3 million in 2010 to 1.7 million in 20237. In addition, the published data showed a 69.6% reduction in a global age-standardized STH prevalence in 2020 compared to 1990 with 75.8%, 59.9% and 82.9% reduction of infections due to Ascaris lumbricoides, Trichuris trichiura and hookworms respectively8. For schistosomiasis, the reduction of DALYs was low, 2.3 million in 2010 to 2.1 million in 20237. The NTD roadmap places increasing emphasis not only on maintaining effective PC, but also on measuring programme impact, adapting the frequency of interventions to the epidemiological situation and progressing towards elimination of schistosomiasis and STH as a public health problem.
Schistosomiasis was endemic in 79 countries in 2025. Transmission of Schistosoma haematobium was confirmed in Cabo Verde, a country which was not previously endemic. In 2025, PC was required for schistosomiasis in 50 countries with 129 million SAC and 107.1 million adults in need of treatment. For STH, PC was required in 84 countries: 247.6 million pre-SAC and 609 million SAC corresponding to approximately 856.6 million children across the two principal target groups.
This report documents global and regional progress in PC coverage for schistosomiasis and STH in 2025 and the impact of control intervention as reported by ministries of health to WHO. An online PC data portal holds details on each endemic country, including data reported by non-governmental organizations after validation by countries. Details of the methods used to collect and analyse data have been published.11 Data from the country reports for 2025 that had not been received at the time of publication will be made available on the PC data portal.